119 related articles for article (PubMed ID: 10573078)
1. Enhanced allograft survival via simultaneous blockade of transferrin receptor and interleukin-2 receptor.
Woodward JE; Bayer AL; Baliga P
Transplantation; 1999 Nov; 68(9):1369-76. PubMed ID: 10573078
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of transferrin receptor blockade on the cellular mechanisms involved in graft rejection.
Bayer AL; Baliga P; Woodward JE
Transpl Immunol; 1999 Sep; 7(3):131-9. PubMed ID: 10608296
[TBL] [Abstract][Full Text] [Related]
3. Transferrin receptor in T cell activation and transplantation.
Bayer AL; Baliga P; Woodward JE
J Leukoc Biol; 1998 Jul; 64(1):19-24. PubMed ID: 9665270
[TBL] [Abstract][Full Text] [Related]
4. T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade.
Woodward JE; Bayer AL; Chavin KD; Blue ML; Baliga P
Transplantation; 1998 Jul; 66(1):14-20. PubMed ID: 9679816
[TBL] [Abstract][Full Text] [Related]
5. Prolongation of allograft survival by administration of mAb specific for the three subunits of IL-2 receptor.
Yasuda K; Nemoto T; Ohashi Y; Satomi S; Murata K; Ishii N; Takeshita T; Sugamura K
Int Immunol; 1998 May; 10(5):561-7. PubMed ID: 9645604
[TBL] [Abstract][Full Text] [Related]
6. Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects.
Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
Transplantation; 1993 Apr; 55(4):901-8. PubMed ID: 8097344
[TBL] [Abstract][Full Text] [Related]
7. Anti-transferrin receptor monoclonal antibody: a novel immunosuppressant.
Woodward JE; Bayer AL; Chavin KD; Boleza KA; Baliga P
Transplantation; 1998 Jan; 65(1):6-9. PubMed ID: 9448136
[TBL] [Abstract][Full Text] [Related]
8. Viral IL-10-induced immunosuppression requires Th2 cytokines and impairs APC function within the allograft.
Qin L; Ding Y; Tahara H; Bromberg JS
J Immunol; 2001 Feb; 166(4):2385-93. PubMed ID: 11160297
[TBL] [Abstract][Full Text] [Related]
9. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
Woodward JE; Qin L; Chavin KD; Lin J; Tono T; Ding Y; Linsley PS; Bromberg JS; Baliga P
Transplantation; 1996 Oct; 62(7):1011-8. PubMed ID: 8878397
[TBL] [Abstract][Full Text] [Related]
10. Neutralization of mouse interleukin-17 bioactivity inhibits corneal allograft rejection.
Chen X; Zhao S; Tang X; Ge H; Liu P
Mol Vis; 2011; 17():2148-56. PubMed ID: 21850190
[TBL] [Abstract][Full Text] [Related]
11. Treatment with interleukin-4 prolongs allogeneic neonatal heart graft survival by inducing T helper 2 responses.
He XY; Chen J; Verma N; Plain K; Tran G; Hall BM
Transplantation; 1998 May; 65(9):1145-52. PubMed ID: 9603159
[TBL] [Abstract][Full Text] [Related]
12. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H
Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251
[TBL] [Abstract][Full Text] [Related]
13. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients.
Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
Transplantation; 1998 Dec; 66(12):1587-96. PubMed ID: 9884244
[TBL] [Abstract][Full Text] [Related]
14. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
[TBL] [Abstract][Full Text] [Related]
15. Prolonged murine cardiac allograft acceptance: characteristics of persistent active alloimmunity after treatment with gallium nitrate versus anti-CD4 monoclonal antibody.
Orosz CG; Wakely E; Sedmak DD; Bergese SD; VanBuskirk AM
Transplantation; 1997 Apr; 63(8):1109-17. PubMed ID: 9133472
[TBL] [Abstract][Full Text] [Related]
16. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting.
Wang H; Hosiawa KA; Min W; Yang J; Zhang X; Garcia B; Ichim TE; Zhou D; Lian D; Kelvin DJ; Zhong R
J Immunol; 2003 Oct; 171(7):3823-36. PubMed ID: 14500684
[TBL] [Abstract][Full Text] [Related]
17. Combination anti-CD2 and anti-CD3 monoclonal antibodies induce tolerance while altering interleukin-2, interleukin-4, tumor necrosis factor, and transforming growth factor-beta production.
Chavin KD; Qin L; Lin J; Woodward JE; Baliga P; Bromberg JS
Ann Surg; 1993 Oct; 218(4):492-501; discussion 501-3. PubMed ID: 8215640
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive effect of the anti-IL-2-receptor monoclonal antibody, AMT-13, on organ-cultured fetal pancreas allograft survival.
Burkhardt K; Loughnan MS; Diamantstein T; Mandel TE
Transplantation; 1988 Nov; 46(5):726-31. PubMed ID: 3057695
[TBL] [Abstract][Full Text] [Related]
19. Administration of anti-interleukin-6 monoclonal antibody prolongs cardiac allograft survival.
Lei J; He F; Wu M; Zheng X; Chen X; Chen Z
Transpl Int; 2010 Dec; 23(12):1271-81. PubMed ID: 20646257
[TBL] [Abstract][Full Text] [Related]
20. Blockade of NKG2D synergized with CTLA4-Ig in promoting long-term graft survival in murine models of cardiac transplantation.
Li J; Zhu H; Wang S; Ye P; Liu C; Wu J; Xia J
Transplantation; 2012 Feb; 93(4):356-63. PubMed ID: 22179404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
